Financhill
Back

iRhythm Technologies Quote, Financials, Valuation and Earnings

iRhythm Technologies Price Quote

$81.75
-0.57 (-0.69%)
(Updated: November 26, 2024 at 12:35 PM ET)

iRhythm Technologies Key Stats

Sell
48
iRhythm Technologies (IRTC) is a Sell

Day range:
$74.31 - $82.50
52-week range:
$55.92 - $124.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.56
P/B ratio:
35.9%

Volume:
515.2K
Avg. volume:
661.1K
1-year change:
-5.11%
Market cap:
$2.6B
Revenue:
$492.7M
EPS:
$-4.86

How Much Does iRhythm Technologies Make?

Is iRhythm Technologies Growing As A Company?

  • What Is iRhythm Technologies's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.18%
  • What Is iRhythm Technologies's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

iRhythm Technologies Stock Price Performance

What Is iRhythm Technologies 52-Week High & Low?

iRhythm Technologies Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy iRhythm Technologies?

Is iRhythm Technologies Cash Flow Positive?

  • What Is IRTC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$31.8M
  • What Is iRhythm Technologies’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $511.9M
  • What Is iRhythm Technologies’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $576K

iRhythm Technologies Return On Invested Capital

  • Is Management Doing A Good Job?
    IRTC return on invested capital is -27.94%
  • What Is iRhythm Technologies Return On Assets?
    ROA measures how assets are converting to revenues and is -20.86%
  • What Is IRTC Return On Equity?
    ROE is a measure of profitability and is -108.99%

iRhythm Technologies Earnings Date & Stock Price

iRhythm Technologies Competitors

  • Who Are iRhythm Technologies's Competitors?
    Below is a list of companies who compete with iRhythm Technologies or are related in some way:
    • Abbott Laboratories (ABT)
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

iRhythm Technologies Dividend Yield

iRhythm Technologies Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -122.32%
Revenue: 18.41% 0.56%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 98.27
Upside from Last Price: 19.38%

Major Shareholders

  • How many IRTC shares are owned by institutional investors?
    52M IRTC shares are owned by institutional investors
  • How many IRTC shares are owned by insiders?
    977.7K IRTC shares are owned by insiders